4.5 Article

Synthesis of T-705-Ribonucleoside and T-705-Ribonucleotide and Studies of Chemical Stability

Journal

CHEMMEDCHEM
Volume 12, Issue 9, Pages 652-659

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201700116

Keywords

antiviral agents; favipiravir; nucleosides; pyrazine ribonucleosides; T-705

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [HU 2350/1-1]

Ask authors/readers for more resources

T-705 (favipiravir) is a fluorinated hydroxypyrazine carboxamide that exhibits antiviral activities against a variety of RNA viruses. Given the lack of potent agents to combat these infections caused by a large number of high-impact pathogens, significant emphasis has been put on studies of the antiviral properties of T-705 and its mechanism of action. T-705 acts as a nucleobase analogue; it is therefore metabolized to the corresponding ribonucleoside triphosphate intracellularly. Herein we report a reliable synthesis of T-705-ribonucleoside as well as its 5'-monophosphate. Moreover, we disclose detailed studies on the remarkable lability of the heterocycle when attached to ribose under very mild conditions, as typically applied in biochemical studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available